Clinical Trial Update: PK and PD of YG1699 in CKD Patients With Diabetes [Phase 1]

View source ↗

Summary

Phase 1 study assessing the pharmacokinetics and pharmacodynamics of YG1699 in patients with diabetes and chronic kidney disease, including those on hemodialysi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetes Mellitus

Drugs mentioned

• YG1699

Snippet

Sponsor: RenJi Hospital | Conditions: Diabetes, Renal Insufficiency, Chronic | Phase 1 | Status: NOT_YET_RECRUITING